1. Introduction {#sec1}
===============

Paratuberculosis (PTB), or Johne\'s disease (JD), is a chronic enteritis of domestic and wild ruminants caused by *Mycobacterium avium* susbp. *paratuberculosis* (*Map*). PTB is responsible for significant economic losses in dairy herds worldwide mainly due to reduced milk yield, reduced reproductive efficiency, premature culling of JD positive animals and reduced cull cow values ([@bib24]; [@bib17]; [@bib15]). Consequently, PTB infection affecting domestic and wild ruminants is a major issue for animal health, and the World Organization for Animal Health (OIE) requires member countries to maintain epidemiological surveillance with notification of disease cases. *Map* spreads through the fecal-oral route, and calves are considered more susceptible to the disease, likely due to their low level of immune-competence ([@bib10]). The disease has a long latent period that depends on individual genetic resistance to infection, farm hygiene, seasonal changes and the level of exposure to *Map* ([@bib11]; [@bib43]). Progressive weight loss, diarrhea and decreased milk yield are the main clinical signs, which are apparent only in advanced stages of disease ([@bib39]). PTB is a worldwide problem, as almost all countries testing for the disease have found *Map*-infected cows. According to the framework of the Animal Health Law Regulation (EU, No, 2016/429), PTB can be considered eligible for the application of disease prevention and control rules. PTB is an OIE-listed disease and must be reported to the OIE as indicated in its Terrestrial Animal Health Code. *Map* might also be of public health concern since an association has been found between *Map* and Crohn\'s disease in humans ([@bib19]).

The control of major mycobacterial diseases affecting livestock such as PTB is a major challenging issue. As the infection with *Map* is not treatable, it is important to control the infection by identifying and culling infected animals and by preventing *Map* transmission to susceptible animals using appropriate hygienic-sanitary strategies ([@bib16]; [@bib14]). Since test and cull programs for JD are time-consuming, expensive, have poor sensitivity and only detect disease in later stages of infection, alternative control strategies are needed. Current inactivated vaccines against PTB are very successful in reducing the presence of *Map* in feces and tissues and in increasing both milk production and cattle productive life, but do not completely clear the infection ([@bib20]; [@bib6]; [@bib4]). Additional obstacles are interference with tests to identify animals infected with *Mycobacterium bovis*, the causal agent of bovine tuberculosis ([@bib13]). Because current prophylactic, diagnostic and therapeutic strategies for PTB have some limitations or are expensive to implement, improving host genetics through selective breeding could enhance natural resistance to *Map* infection and complement existing control strategies ([@bib41]).

Over the last decade, specific candidate genes have provided evidence for the existence of genomic variations associated with differences in *Map* susceptibility in cattle, sheep and goats ([@bib30]). This has been informed in part by studies on genetic susceptibility to other mycobacterial diseases, including tuberculosis in humans and cattle, with many correlates found. Most candidate gene discovery studies for *Map* susceptibility use a case-control design, where samples are selected from a set of cases (infected animals) and controls (animals exposed but not infected) in a population reference. Candidate genes have single nucleotide polymorphisms (SNPs) for which the frequency in cases and controls differs. Previously, we performed a case-control study in 636 Spanish Holstein cows that were slaughtered in Spanish abattoirs during a two year period. Animals were phenotyped for *Map* infection using a histopathological analysis of gut tissues and classified into three epidemiologically pathogenic forms of disease according to the severity of the lesions: i) apparently free of infection, cows with no detectable lesions; ii) latent PTB, cows with focal lesions; and iii) patent PTB; cows with more advanced lesions such as multifocal or diffuse lesions ([@bib42]). Our case-control study identified 24 SNPs that were associated with susceptibility/resistance to *Map* infection in bovine genes that encode pattern recognition receptors in macrophages and dendritic cells such as the *nucleotide-binding oligomerization domain 2* (*NOD2*), *dendritic cell-specific ICAM-3-grabbing non-integrin dectin-1* (*DC-SIGN* or *CD209*), and the *Toll-like receptors 2* and *4* (*TLR2* and *TLR4*) ([@bib33], [@bib36], [@bib37]). Other SNPs were identified in candidate genes encoding regulators of the innate immune response, such as the *solute carrier family 11 member A1 gene* (*SLC11A1*) and the *nuclear body protein SP110* ([@bib34], [@bib35]). The 24 SNPs fit three quality parameters: sample call rate (\>80 %), SNP call rate (\>80 %) and Hardy-Weinberg equilibrium.

A previous genetic analysis suggested that genotypic combinations should provide more information than individual SNPs for association studies ([@bib28]). Using combinations of the 24 previously identified SNPs, we found a set of five SNPs that best explained the variation in disease progression in our case-control population. This is important because the effect of host genotype on disease progression, shedding and immune response is not completely understood. More specifically, we proposed that 70 genetic combinations in 5 SNPs could explain differences in the infection progression, which was graded as low (LOWIN), latent (LATIN), or patent (PATIN) risk ([@bib21]). Other possible combinations of these 5 SNPs were grouped in the average risk category (AVERIN). The main objective of the current study was to evaluate the relationships between these risk groups and the estimated breeding values (EBVs) for several type, production and functional traits. For this purpose, we genotyped and classified a large cohort of Spanish Holstein cows (N = 15656) in the genetic risk groups, and then we analyzed the EBVs for several traits included in the Spanish combined genetic index. In addition, the associations between the risk groups and PTB diagnostic results were validated in 99 lactating cows from a Spanish farm with a high PTB prevalence. This approach allowed us to validate the association between a high risk for clinical PTB and positive ELISA and fecal PCR results.

2. Materials and methods {#sec2}
========================

2.1. Ethics statement {#sec2.1}
---------------------

Experimental procedures were approved by the Animal Ethics Committee of the Servicio Regional de Investigation y Desarrollo Agroalimentario (SERIDA) and authorized by the Regional Consejeria de Agroganadería y Recursos Autoctonos of the Principality of Asturias (authorization code PROAE 29/2015). Experimental procedures were conducted according to the European Community Council Animal Welfare Guidelines (2010/63/EU). Blood samples were collected under the supervision of official veterinarians and in accordance with good veterinary practice. Otherwise, the study was restricted to routine on-farm observations and measurements that did not inconvenience or stress the animals.

2.2. Animals {#sec2.2}
------------

Genotypes and EBVs corresponding to 15656 cows that were genotyped with the Illumina LD EURO G10K BeadChip in 2016 or 2017 were provided by the Spanish Federation of Holstein Cattle (CONAFE). For the second part of the study, blood and fecal samples were collected from 99 cows from a single commercial dairy farm in Asturias (Spain). This farm had a past history of PTB clinical cases, with some cows confirmed by necropsy examination. The mean prevalence of the disease in this farm as estimated by ELISA was 6.29 %. The mean age of the herd was 3.95 years (range, 1.05--10 years). Our study assesses associations between functional and genetic characteristics, and it adheres to the reporting of the genetic association studies (STREGA) initiative ([@bib22]).

2.3. Blood sampling, DNA extraction, genotyping and predicted risk of infection progression {#sec2.3}
-------------------------------------------------------------------------------------------

Blood samples were collected from the coccygeal (tail) vein into EDTA Vacutainer tubes (BD Vacutainer System, Becton, Dickinson and Company, Sparks, MD, USA). Blood samples were centrifuged at 2500 x g for 20 min at 4 °C and buffy layers containing white blood cells were collected. Genomic DNA was extracted from the blood buffy coat using the QIAmp DNA Blood Mini Kit according to the manufacturer\'s instructions (Qiagen, Hilden, Germany). Purified genomic DNA was quantified and subsequently genotyped using the Illumina LD EURO G10K BeadChip, which includes the following five SNPs in the bovine genes: *SLC11A1* (SNP1: rs110090506), *SP110* (SNP2: rs136859213, SNP3: rs1100480812), *TLR2* (SNP4: rs41830058) and *CD209* (SNP5: rs210748127) ([Table 1](#tbl1){ref-type="table"}). The EURO G10K BeadChip was developed by EuroGenomics and its collaborators. SNP1 and SNP2 are intronic. SNP3 is located in the coding region of exon 5 and causes an amino acid change from asparagine to serine at codon 196 (p.Asn196Ser). SNP4 in exon 2 and SNP5 in exon 8 do not result in any amino acid changes. DNA samples were genotyped at the molecular genetic laboratory service of the Spanish Federation of Holstein Cattle using the InfiniumTM iScan software (Illumina, San Diego, CA) for allele assignation. Animals were then assigned to a low (LOWIN), latent (LATIN), patent (PATIN) or AVERIN risk group according to 70 genetic combinations (Supplementary Table S1) ([@bib21]). These 70 combinations contain 24 genotypes that belonged to the LOWIN group, 12 to the LATIN, 8 to the PATIN and 26 to the AVERIN risk group.Table 1SNPs in the SLC11A1, SP110, TLR2, and CD209 genes used in the current study.Table 1GeneSNP [1](#tbl1fn1){ref-type="table-fn"}Chromosomal position (bp)Major and minor allelesFuntional ConsequenceReferenceSLC11A1rs110090506Cr:2:107122737c.1157-91A \> Tintron variant[@bib35]SP110rs136859213Cr:2:119123998c.-1974C \> Tintron variant[@bib34]rs110480812Cr:2:119109955c.587A \> GmissenseTLR 2rs41830058Cr:17:3951480c.1707T \> Csynonymous codon[@bib36]CD209rs210748127Cr:7:17811240c.762T \> Csynonymous codon[@bib37][^1]

2.4. Estimated breeding values (EBVs) {#sec2.4}
-------------------------------------

Genomic EBVs reflect the genetic potential or merit of an animal for a specific trait. The genomic EBVs are calculated by CONAFE for individual animals using the SNP BLUP method. This method is a BLUP using a genomic relationship matrix as a matrix of relationships between genotypes. BLUP assumes that all SNPs have the same variance, and it follows a normal distribution. The genomic matrix, called M, is a matrix of the codified SNPs in each animal. The genomic evaluation is a single trait assessment, where the linear model that is used to estimate the direct genomic values (VGDs) of each character is written as follows: y = 1μ+Mg + e, where y: De-regressed proofs (PDR) of the Reference Population animals for a given trait, calculated from the current MACE proofs published by Interbull ([@bib18]). μ: Population average. g: Random SNP effects vector. M: Design matrix relating the genetic effects of SNPs with phenotypic data (in this case, PDR). Normal distributions for genetic (g) and environmental (e) effects are assumed. Three times a year (March, June and November) the de-regressed proofs from the last MACE evaluation were calculated, and the Reference Population was updated in order to calculate the genomic EBVs of all genotyped animals recorded in the CONAFE database. More information about the genomic evaluation of the Holstein breed in Spain can be found at CONAFE (<http://213.0.29.171/IndicesGen/Docs/evaluaciones_Metodologia_Genomica_EN.pdf>). For large-scale genetic and genomic evaluations of Spanish dairy cattle, CONAFE uses the MiX99 software (MiX99 Development Team, 2017). Only records from cows in official milk recording, in the herd book and with known sire and dam were considered. Close lactations and records of culled cows were included and projected to 305 days, if days in milk ≥215. The records in progress were included, and projected to 305 days if days in milk ≥65 ([@bib25]). Management variables such as diet were taken into account when the EBVs for milk yield were calculated. To eliminate the influence of other environmental factors affecting cattle productive life, all of the lactations for each individual cow were considered.

The EBVs for milk yield (kg), milk fat (kg), milk protein (kg), longevity score, days open (DO), functional merit index (ICOT), economic merit index (ECM), and the combined genetic index (ICO) were obtained from the 2019 CONAFE evaluation. ICO is the official index for total genetic merit. It combines the different traits according to their economic importance and their genetic correlations. It is used to rank the animals in the official lists of the best cows genotyped, with the breeding objective to improve future profitability of farms. The somatic cell score (SCS) is the arithmetic mean of monthly test of somatic cells that is transformed using a base-2 logarithmic function ([@bib2]). The longevity score is measured as the number of days between the first calving and last milk record. DO is the time from when a cow calves until it conceives. The 2019-ICO consists of the following components: milk yield (11 %), fat yield (17 %), protein yield (21 %), feet and legs score (8 %), combined udder index (12 %), claw health index (4 %), SCS (8 %), longevity score (11 %), and DO (8 %). The functional merit index (ICOT) consists of the same traits as the ICO, excluding the production traits. The economic merit index (ECM) is expressed as a financial value in euros and reflects the expected increase in revenue per lactation relative to an animal with an ECM of zero ([@bib9]).

2.5. Enzyme-linked immunosorbent assay (ELISA) for the detection of Map-specific antibodies {#sec2.5}
-------------------------------------------------------------------------------------------

Blood was collected from the coccygeal (tail) vein of each animal into 4.5 ml serum clot activator Vacutainer® tubes (Vacuette, Kremsmunster, Austria). After clotting, serum was separated by centrifugation (2500 x g for 20 min) and stored at -20 °C until use. The serum samples were tested in duplicate using the *Mycobacterium paratuberculosis* antibody test kit (IDEXX laboratories, Oofddorp, The Netherlands) according to the manufacturer\'s instructions. The optical density (OD) at 450 nm was measured in each well by an ELISA plate reader (model 680, Sigma, St. Lois, MO). The measured ODs were normalized, and the results were expressed as a percentage of the positive control OD according to the following formula: % relative OD sample/OD positive control = 100 X \[(OD sample + Ag - OD sample - Ag)/(OD positive control + Ag -- OD positive control - Ag). Samples with a ≥55 % relative OD/OD positive control were considered positive.

2.6. Fecal real-time polymerase chain reaction (PCR) and quantitative PCR (qPCR) {#sec2.6}
--------------------------------------------------------------------------------

Isolation of genomic DNA from feces was performed using the MagMax Total Nucleic Acid Isolation kit according to the manufacturer\'s instructions (ThermoFisher Scientific, Lissieu, France). The kit employs mechanical disruption of the samples with zirconia beads in a guanidinium thiocyanate-based solution that rapidly releases nucleic acids while it simultaneously inactivates nucleases in the sample. Samples were then diluted with isopropanol, and paramagnetic beads with nucleic acid binding surface were added to the sample. For the detection of *Map* DNA, the LSI VetMax Triplex real-time PCR was used according to the manufacturer\'s instructions (ThermoFisher Scientific, Lissieu, France). Real-time PCR amplifications were performed using the MX3000P Real-Time PCR detection system (Stratagene, San Diego, USA) with the following conditions: 1 cycle at 50 °C for 2 min, 1 cycle of denaturation at 95 °C for 10 min, 45 cycles of denaturation at 95 °C for 15 s, and annealing/extension at 60 °C for 60 s. Samples with Ct values lower than 45 for the IS900 and F57 targets were considered positive. Fecal samples were also tested with the ParaTB Kuanti-VK kit following the manufacturer\'s instructions (Vacunek, Bizkaia, Spain). The kit uses a F57 TaqMan probe that is labeled with the fluorescent reporter dye 5-carboxyfluorescein (FAM) at the 5′ end and primers that specifically amplify the single-copy F57 insertion sequence of *Map*. Inhibition of the amplification reaction is ruled out by including an internal hybridization probe labeled with 6-carboxy-4′,5′-dichloro-2′,7′-dimethosyfluorescein succinimidyl ester (JOE) at the 5′-end and specific primers. This internal amplification control molecule is co-amplified alongside the F57 diagnostic target in a duplex format. Quantification of *Map* titer (F57 copy numbers per gram of feces) was accomplished by preparing a standard curve using serial dilutions of a standard sample containing a known number of MAP DNA copies. Real-time qPCR amplifications were performed using the Step One Plus detection system (Applied Biosystems, Carlsbad, CA) with the following conditions: 1 cycle of denaturation at 95 °C for 10 min, 45 cycles of denaturation at 95 °C for 15 s, and annealing/extensions at 60 °C for 60 s. The results were analyzed with ABI Prism software version 1.4. This F57 real-time qPCR assay was able to quantify 10 to 10^7^ copies/reaction.

2.7. Statistical analysis {#sec2.7}
-------------------------

We used a generalized linear model (GLM) or multivariate regression model to model the relationships between multiple independent (predictive or explanatory) variables and a single dependent (predicted) variable, which was the risk of PTB progression with the following four degrees: AVERIN, LOWIN, LATIN and AVERIN. The independent variables were the EBVs, ELISA readings and *Map* DNA copies/gram of feces. Differences between the four risk groups in the least squares means of the EBVs for several traits were estimated by analysis of variance using the GLM procedure of the SAS 9.1. statistical package for Windows (SAS Institute Inc, Cary, NC, USA). Pearson correlations between the risk groups and EBVs for several traits were calculated with the CORR procedure of the SAS 9.1. statistical package.

In addition, the associations between the genetic risk groups and diagnostic results (mean ELISA readings and *Map* DNA copies/gram of feces) were estimated in a population of 99 cows from a Spanish farm with a high prevalence of PTB by analysis of variance using the GLM procedure of the SAS 9.1 statistical package. The independent variables were the ELISA readings and *Map* DNA copies/gram of feces In all of the analyses, the least squares means of the independent variables were estimated and compared with the Tukey-Kramer correction for multiple comparisons. Statistical analyses resulting in P values lower than 0.05 were considered to be significant.

3. Results {#sec3}
==========

3.1. Genotyping, risk group assignment and associations with estimated breeding values for several traits {#sec3.1}
---------------------------------------------------------------------------------------------------------

A large cohort of Spanish cattle (N = 15656) was genotyped and classified in four genetic risk groups as previously described ([@bib21]). After the assignment of each individual cow to a risk group, we observed that 7.83 % of the cows were classified in the LOWIN risk group, 2.44 % in the LATIN, 9.24 % in the PATIN and 80 % in the AVERIN risk group ([Table 2](#tbl2){ref-type="table"}). Next, differences in the EBVs for several productions, types, and functional traits currently included in the Spanish breeding goal were analyzed. As seen in [Figure 1](#fig1){ref-type="fig"}, cows within the PATIN risk group (N = 1448) had a superior combined genetic index (2797.57), functional merit index (524.62), milk yield (653.92 kg), fat yield (24.82 kg), and protein yield (21.77 kg) compared with the other three risk groups. As seen in [Figure 1](#fig1){ref-type="fig"}F, statistically significant differences in longevity scores between the cows included in the PATIN risk group (108.85) and the LOWIN (107.82) and AVERIN (107.92) cows were also observed; P = 0.0132 and P = 0.0008, respectively. However, no significant differences in longevity scores were found between the PATIN (108.85) and the LATIN (108.66) cows. Differences between the risk groups in mean economic profit index were also estimated. As seen in [Figure 2](#fig2){ref-type="fig"}, cows within the PATIN risk group had superior economic merit index per year of productive life (125.25 €) compared to the cows included in the LATIN (111.11 €), LOWIN (110.17 €), and AVERIN (112.64 €) risk groups. Finally, the Pearson correlations between the cows classified in the risk groups and EBVs for several types, productions, and functional traits were calculated. As seen in [Table 3](#tbl3){ref-type="table"}, a trend is consistent for the different EBVs across the risk of infection. A positive correlation between the PATIN risk group and all of the variables that were included in the combined genetic index was observed (0.06), which suggests that animals that are prone to develop PTB clinical signs are also capable of producing higher yields. A high milk yield is a predisposing factor in the development of clinical PTB. In contrast, negative correlations between the LOWIN and AVERIN groups and the combined genetic indexes were estimated (-0.02). No statistically significant correlations were observed between the LATIN risk group and the EBVs of the analyzed traits.Table 2Estimated risk of infection progression of 15656 genotyped cows.Table 2Risk groupGenotypes codes (Nº of cows with a specific genotype)Animals (N)Animals (%)PATIN6 (13), 15 (38), 21 (119), 29 (179), 42 (84), 45 (267), 46 (690), 61 (58)14489.24LATIN8 (23), 25 (31), 26 (95), 32 (132), 35 (10), 37 (9), 38 (5), 39 (47), 60 (8), 65 (8), 70 (12)3802.44LOWIN1 (4), 4 (57), 5 (125), 7 (17), 9 (48), 10 (21), 11 (46), 12 (13), 13 (3), 14 (2), 31 (53), 34 (78), 36 (41), 48 (255), 49 (6), 50 (66), 52 (10), 58 (80), 62 (153), 63 (30), 66 (17), 67 (30), 68 (68), 69 (3)12267.83AVERIN2 (35), 3 (117), 16 (283), 17 (897), 18 (42), 19 (442), 20 (1110), 22 (365), 23 (38), 24 (125), 27 (149), 28 (334), 30 (370), 33 (25), 40 (646), 41 (1604), 43 (804), 44 (2172), 47 (91), 51 (196), 54 (259), 55 (617), 56 (307), 57 (731), 59 (228), 64 (107), other genotypes (508)1260280.49[^2]Figure 1Differences between the risk groups in mean estimated breeding values for several traits. The 15656 Holstein cows that were genotyped for the 5 SNPs in bovine *CD209, SLC11A1*, *SP110*, and *TLR2* genes in 2016 or 2017 were assigned to a LOWIN, LATIN, PATIN or AVERIN risk of PTB progression. A linear model was used to test if the 2019 EBVs of the four risk groups differed. The EBV of the following traits were included in the analysis; type genetic index (A), combined genetic index (B), milk yield (C), fat yield (D), protein yield (E), and the longevity score(F). The blue bar represents the PATIN risk group, the red bar corresponds to the LATIN risk group, and the LOWIN and AVERIN groups are represented with green and purple bars, respectively. The variability of the mean values is represented by the standard error. Statistically significant differences are represented with an asterisk.Figure 1Figure 2Differences in the economic merit index between the four risk groups. The differences in the mean economic merit index of the four risk groups were estimated in a population of 15656 Holstein cows genotyped across Spain in 2016 or 2017. The blue bar represents the PATIN risk group, the red bar corresponds to the LATIN risk group, and the LOWIN and AVERIN groups are represented with green and purple bars, respectively. Statistically significant differences are represented with an asterisk.Figure 2Table 3Pearson correlation coefficients between the risk groups and EBVs for several traits.Table 3Functional genetic indexCombined genetic indexMilk (Kg)Fat (Kg)Protein (kg)Longevity scorePATINCorrelation**0.03040.06260.03420.04390.05530.0302**P**0.0001\<0.0001\<0.0001\<0.0001\<0.00010.0002**LATINCorrelation-0.0057-0.1189-0.0095-0.0061-0.01070.0116P0.46870.13680.23290.44030.17880.1400LOWINCorrelation**-0.0233-0.0269**-0.0011**-0.0207**-0.0094-0.0066P**0.00350.0070**0.8829**0.0093**0.23700.4056AVERINCorrelation-0.0041**-0.0229-0.0205**-0.0156**-0.0298-0.0220**P0.6025**0.00420.0101**0.0505**0.00200.0057**[^3]

3.2. Genotyping, risk group assignment and associations with diagnostic tests {#sec3.2}
-----------------------------------------------------------------------------

A total of 99 cows from a Spanish farm with a high prevalence of clinical PTB were genotyped for the 5 selected SNPs ([Table 1](#tbl1){ref-type="table"}). Animals were then assigned to the LOWIN, LATIN, PATIN or AVERIN risk groups as previously described ([@bib21]) Three of the 99 cows belonged to the PATIN risk group (3.03 %), 6 were LATIN (6.06 %) and 9 LOWIN (9.09 %) ([Table 4](#tbl4){ref-type="table"}). The remaining 81.81 % of cows were classified within the AVERIN risk group. As shown in [Figure 3](#fig3){ref-type="fig"}A, significant differences in mean ELISA readings between the animals included in the PATIN risk group (65.49) and the AVERIN (15.97), LATIN (2.11), and LOWIN (3.27) groups were observed, at P = 0.027, P = 0.018 and P = 0.014, respectively. This result shows a positive association between the ELISA readings and the genetic combinations of the animals within the PATIN risk group. In addition, significant differences in mean log *Map* DNA copies/gr of feces were observed between the PATIN group (5.09) and the AVERIN (3.106), LATIN (0) or LOWIN (0) groups, at P = 0.013, P = 0.014, and P = 0.009, respectively ([Figure 3](#fig3){ref-type="fig"}B).Table 4Classification of the cows from the on-farm study (N = 99) in risk groups.Table 4Risk GroupGenotypes codes (Nº of cows with a specific genotype)Animals (N)Animals (%)PATIN15 (1), 29 (1), 45 (1)33.03LATIN25 (1), 26 (2), 32 (1), 39 (2)66.06LOWIN5 (1), 31 (1), 34 (2), 48 (2), 62 (2), 67 (1)99.09AVERIN16 (1), 17 (8), 19 (3), 20 (12), 22 (1), 24 (1), 28 (1), 30 (2), 40 (6), 41 (9), 43 (8), 44 (10), 47 (2), 54 (2), 55 (3), 56 (1), 57 (3), 59 (2). New genotypes (6).8181.81[^4]Figure 3Associations between the risk groups and PTB diagnostic tests in Holstein cattle from a commercial Spanish farm. (A) Mean ELISA readings for the detection of *Map*-specific antibodies. The measured ODs were normalized, and the results were expressed as a percentage of the positive control. (B) Mean log *Map* DNA copies/gr of feces quantified by qPCR. The blue bar represents the PATIN risk group, the red bar corresponds to the LATIN risk group, and the LOWIN and AVERIN groups are represented with green and purple bars, respectively. The variability of the results is represented by the standard error. Statistically significant differences are represented with an asterisk.Figure 3

4. Discussion {#sec4}
=============

It is generally accepted that intensive selection for high milk production, with limited emphasis on health and longevity traits, increases the incidence of health problems such as mastitis, milk fever, retained fetal membranes and gastrointestinal conditions during the periparturient period ([@bib1]). [@bib29] showed that higher yielders tend to be more commonly affected by mastitis accompanied by higher SCS, higher lameness incidence, increased calving interval and days to first service, increased number of inseminations and increased returns to service. However, there is no consensus in the literature regarding correlations between genetic susceptibility/resistance to *Map* infection and EBVs for several type, production and functional traits. Recently, [@bib8] estimated the genetic parameters for the *Map*-specific antibody response using milk ELISA scores in Canadian Holstein cattle as an indicator of resistance to PTB. Correlations between resistance to PTB and higher EBVs for several traits in Canada were considered favorable, with the exception of SCS. In the current study, the correlations between genetic risk groups of PTB progression and the 2019-EBVs for several production, type and functional traits were analyzed in 15656 Holstein cattle that were genotyped across Spain in 2016 and 2017. Our results showed a positive association between a high risk of clinical PTB and high EBVs for most of the traits included in the Spanish combined genetic index. Differences among both studies may be due to many factors such as variable diagnostic tests, variable disease incidence in the studied populations, different management practices, different trait definitions and others. It should be considered that our results are based on the genetic risk groups that are able to predict future PTB outcome early in life. *Map* infection occurs in calves at a young age, but clinical signs such as reduced milk yield appear later in life. Therefore, most of the animals in the PATIN group might be at a high risk of developing clinical infection without actually showing reduced milk yield yet. In fact, early work by Tiwari et al. found no association between *Map* and lower milk yield until lactation 4 or greater ([@bib40]). Other studies showed that cows that ultimately tested positive had a higher milk production before their first positive test than cows that never tested positive ([@bib23]; [@bib38]).

According to [@bib7] a breeding goal should include increased income (higher production of milk), reduced cost (better fertility, fewer diseases, and reduced culling rates), ease of management (temperament and milking speed), and advantages regarding the sale of products (animal welfare, ethics, and consumer concerns). Since only healthy cows can perform at high levels of production, breeding programs are focusing on reducing diseases and improving functional traits ([@bib32]; [@bib44]). The main challenge is to balance high levels of production and profit with fertility, longevity and health through genetic selection ([@bib12]). Trait definitions, combined genetic indexes and models of analysis vary between countries. The Spanish combined genetic index (ICO) includes the lactation somatic cell score (SCS) and the combined udder score (ICU) as indicators of mastitis resistance ([@bib26]). More recently, the claw health index has been included in the ICO ([@bib27]). In the United Kingdom (UK), genetic selection for increased resistance to bovine tuberculosis has shown a favorable effect on cow longevity and on the profit lifetime index (PLI), which effectively combines production, durability, health and fertility in one single value. This is consistent with the UK PLI placing over 20 % of its emphasis on health and fertility traits ([@bib5]).

The current study links the genetic risk for clinical PTB with production using a large cohort of Spanish cattle. In addition, the associations between the risk groups and diagnostic results were evaluated in 99 lactating cows from a PTB-infected dairy farm. Positive associations between the cows that were classified within the PATIN risk group and positive ELISA and fecal PCR results were obtained. By contrast, we could not detect any association between the positive diagnosis results and the genotypic combinations of the cows that were included in the LATIN risk group, probably due to the relatively late onset of fecal shedding and delayed production of antibodies during the natural course of *Map* infection, which only allows a definitive detection of animals in the advanced stages of PTB. Until a very sensitive diagnostic tool is developed that identifies cattle with early or chronic disease, the struggle of identifying and validating the genomic regions that are associated with PTB susceptibility/resistance will continue. Recent transcriptomic studies using RNA-Seq technology suggest that some host genes, which are biomarkers, are differentially expressed in the gut tissues and blood of PTB-infected animals depending on disease status ([@bib3]). Using novel biomarker-based diagnostic assays, we could potentially detect infected cattle at an earlier age than is possible with current ELISA and PCR-based diagnostic assays.

Although we recognize that the population size used in the second part of the study is small (N = 99); the association between the genotypic combinations of the cows included in the PATIN risk group and positive ELISA and fecal PCR results was demonstrated. Using this independent population, we were able to validate the genotypes that were previously identified to be associated with the highest risk of disease progression by testing their association with ELISA and fecal PCR results. Overall, our results support the hypothesis that genetic variants in the bovine *CD209*, *SLC11A1*, *SP110*, and *TLR2* genes are associated with the outcome of *Map* infection in cattle. However, we cannot exclude the possibility that polymorphisms in other genes involved in the host innate immune response might also be associated with disease progression.

The prospects of including PTB into the Spanish selection program are convincing despite the moderate hereditability of the trait. It should be acknowledged that while hereditability of clinical mastitis in dairy cattle is low, the SCS is included in selective breeding programs in many countries including Spain. The selection for health traits such as mastitis and PTB should reduce the need for involuntary culling due to disease. Reducing the occurrence of cattle at a high risk of progression to a clinical state through selective breeding would reduce *Map* infection and transmission between cattle over time and would particularly increase cattle productive life if used in combination with other control measures such as vaccination and biosafety practices. Similarly, the potential of a herd to pass infection to the environment, wild ruminants and reservoirs would also be reduced. Selection for PTB resistance would particularly benefit high risk geographic areas where the disease is highly prevalent, vaccination is not allowed and highly resistant sires are required. In addition, the genetic improvement of PTB resistance should in turn lead to simultaneous improvement of longevity, thus capturing a greater potential milk yield from older cows. Increasing the survival of milking cows is expected to have not only economic benefits but also social and environmental benefits by means of reducing farm costs.

In conclusion, our results showed a positive association between a high risk of clinical PTB and high EBVs for most of the traits included in the Spanish combined genetic index. This unfavorable correlation emphasizes the need for the inclusion of PTB resistance as a novel trait into the Spanish selection program. However, further research is required to determine optimal selection methods in order to exclude those cows with a high risk of clinical PTB.
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[^1]: Genbank accession number.

[^2]: LOWIN- Low risk of infection progression, LATIN- risk of progression to a latent form of disease, PATIN- risk of progression to a patent form of disease, AVERIN- animals with SNPs combinations that did not fit into any of the mentioned groups. SNPs combinations defining each risk group are included in Supplemental Table 1. Genotypes not previously identified were classified as new genotypes.

[^3]: Significant correlations (P ≤ 0.05) are shown in bold.

[^4]: LOWIN- Low risk of infection progression, LATIN-risk of progression to a latent form of disease, PATIN- risk of progression to a patent form of disease, AVERIN- animals with SNPs combinations that did not fit into any of the mentioned groups. SNPs combinations corresponding to each risk group are included in Supplemental Table 1. Genotypes not previously identified were classified as new genotypes.
